ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000024325
Date of registration:	06/10/2016
Prospective Registration:	No
Primary sponsor:	Juntendo University
Public title:	Efficacy of neovascularization with quality and quantity control cultured peripheral blood stem cell in fat grafting
Scientific title:	Efficacy of neovascularization with quality and quantity control cultured peripheral blood stem cell in fat grafting - Efficacy of neovascularization with quality and quantity control cultured peripheral blood stem cell in fat grafting
Date of first enrolment:	2016/10/01
Target sample size:	90
Recruitment status:	Recruiting
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027902
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not selected

Countries of recruitment
Japan

Contacts

Name:	Rica Tanaka
Address:	Hongo 2-1-1, Bunkyo-ku, Tokyo, Japan Japan
Telephone:	03-3813-3111
Email:	rtanaka@juntendo.ac.jp
Affiliation:	Juntendo University School of Medicine Department of Plastic and Reconstructive Surgery

Name:	Rica Tanaka
Address:	Hongo 2-1-1, Bunkyo-ku, Tokyo, Japan Japan
Telephone:	03-3813-3111
Email:	rtanaka@juntendo.ac.jp
Affiliation:	Juntendo University School of Medicine Department of Plastic and Reconstructive Surgery

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: The patiets have 1. Smoker 2. Age under 19 or over 81 3. Diabetes 4. hematological abnormalities or malignant processes 5. chemotherapy 6. connective tissue diseases 7, lipodystrophy 8. other (the patients whom the principal investigator assessed as the inappropriate subjects)

Age minimum: 20years-old
Age maximum: 80years-old
Gender: Male and Female

Health Condition(s) or Problem(s) studied

Fat Grafting

Intervention(s)

Blood Collection

Primary Outcome(s)

1. Fat graft viability 2. Fat graft quality 3. Fat graft vascularization 4. Gene expression

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Self funding

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date: 22/03/2019
Contact:

Results

Results available:	Yes
Date Posted:
Date Completed:	31/03/2024
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.